The short version
5 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
PEG 3350 and Electrolytes
Polyethylene Glycol 3350, Sodium Sulfate Anhydrous, Sodium Bicarbonate, Sodium Chloride, Potassium Chloride · POLYETHYLENE GLYCOL 3350 236 g/4L; SODIUM SULFATE ANHYDROUS 22.74 g/4L; SODIUM BICARBONATE 6.74 g/4L; SODIUM CHLORIDE 5.86 g/4L; POTASSIUM CHLORIDE 2.97 g/4L · Powder, For Solution · Oral · A-S Medication Solutions
NDC 50090-8020-00 · 4 L in 1 JUG · NDA AUTHORIZED GENERIC · View full market →
Medicare Part D
All Part D pricing →Matched to CMS's representative package for this drug (NDC 10572-0100-01) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.
ⓘ How this was built
Data sources
- CMS quarterly Prescription Drug Plan Formulary & Pricing files (SPUF)
Method
Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
Plans pay at point of saleⓘ
$0.0081per unit
middle half $0.0067–$0.0133 · 5,449 plans · Apr 1, 2026
Est. net of rebatesⓘ
≈ $0.0081
generic — rebates are minimal, so net ≈ gross
Coverage & restrictions
99%of plans cover it
tier 2 · prior auth 0% · step therapy 0% · qty limit 0%
*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 10 quarters since 2024.
NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for polyethylene glycol 3350, sodium sulfate anhydrous, sodium bicarbonate, sodium chloride, potassium chloride (other) in the next 90 days
sole-source market · price up 2% YoY
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Regulatory
- Application
- NDA019011
- TE code
- AA
- Approval date
- Jul 13, 1984
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Polyethylene Glycol 3350, Sodium Sulfate Anhydrous, Sodium Bicarbonate, Sodium Chloride, Potassium Chloride (Powder, For Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| A-S Medication Solutions | POLYETHYLENE GLYCOL 3350 236 g/4L; SODIUM SULFATE ANHYDROUS 22.74 g/4L; SODIUM BICARBONATE 6.74 g/4L; SODIUM CHLORIDE 5.86 g/4L; POTASSIUM CHLORIDE 2.97 g/4L | Aug 26, 2026 | Sep 2, 2026 |
| Affordable Pharmaceuticals, LLC | POLYETHYLENE GLYCOL 3350 236 g/4L; SODIUM SULFATE ANHYDROUS 22.74 g/4L; SODIUM BICARBONATE 6.74 g/4L; SODIUM CHLORIDE 5.86 g/4L; POTASSIUM CHLORIDE 2.97 g/4L | Aug 26, 2026 | Sep 2, 2026 |
| Azurity Pharmaceuticals, Inc. | POLYETHYLENE GLYCOL 3350 236 g/4L; SODIUM SULFATE ANHYDROUS 22.74 g/4L; SODIUM BICARBONATE 6.74 g/4L; SODIUM CHLORIDE 5.86 g/4L; POTASSIUM CHLORIDE 2.97 g/4L | Aug 26, 2026 | Sep 2, 2026 |
| Braintree Laboratories, Inc. | POLYETHYLENE GLYCOL 3350 236 g/4L; SODIUM SULFATE ANHYDROUS 22.74 g/4L; SODIUM BICARBONATE 6.74 g/4L; SODIUM CHLORIDE 5.86 g/4L; POTASSIUM CHLORIDE 2.97 g/4L | Aug 26, 2026 | Sep 2, 2026 |
| Wilshire Pharmaceuticals, Inc. | POLYETHYLENE GLYCOL 3350 236 g/4L; SODIUM SULFATE ANHYDROUS 22.74 g/4L; SODIUM BICARBONATE 6.74 g/4L; SODIUM CHLORIDE 5.86 g/4L; POTASSIUM CHLORIDE 2.97 g/4L | Aug 26, 2026 | Sep 2, 2026 |
| A-S Medication Solutions | POLYETHYLENE GLYCOL 3350 236 g/4L; SODIUM SULFATE ANHYDROUS 2.97 g/4L; SODIUM BICARBONATE 6.74 g/4L; SODIUM CHLORIDE 5.86 g/4L; POTASSIUM CHLORIDE 22.74 g/4L | Jul 22, 2026 | Aug 22, 2026 |
| Affordable Pharmaceuticals, LLC | POLYETHYLENE GLYCOL 3350 236 g/4L; SODIUM SULFATE ANHYDROUS 2.97 g/4L; SODIUM BICARBONATE 6.74 g/4L; SODIUM CHLORIDE 5.86 g/4L; POTASSIUM CHLORIDE 22.74 g/4L | Jul 22, 2026 | Aug 19, 2026 |
| Azurity Pharmaceuticals, Inc. | POLYETHYLENE GLYCOL 3350 236 g/4L; SODIUM SULFATE ANHYDROUS 2.97 g/4L; SODIUM BICARBONATE 6.74 g/4L; SODIUM CHLORIDE 5.86 g/4L; POTASSIUM CHLORIDE 22.74 g/4L | Jul 22, 2026 | Aug 19, 2026 |
| Braintree Laboratories, Inc. | POLYETHYLENE GLYCOL 3350 236 g/4L; SODIUM SULFATE ANHYDROUS 2.97 g/4L; SODIUM BICARBONATE 6.74 g/4L; SODIUM CHLORIDE 5.86 g/4L; POTASSIUM CHLORIDE 22.74 g/4L | Jul 22, 2026 | Aug 19, 2026 |
| Wilshire Pharmaceuticals, Inc. | POLYETHYLENE GLYCOL 3350 236 g/4L; SODIUM SULFATE ANHYDROUS 2.97 g/4L; SODIUM BICARBONATE 6.74 g/4L; SODIUM CHLORIDE 5.86 g/4L; POTASSIUM CHLORIDE 22.74 g/4L | Jul 22, 2026 | Aug 19, 2026 |
| A-S Medication Solutions | POLYETHYLENE GLYCOL 3350 236 g/4L; POTASSIUM CHLORIDE 2.97 g/4L; SODIUM BICARBONATE 6.74 g/4L; SODIUM CHLORIDE 5.86 g/4L; SODIUM SULFATE ANHYDROUS 22.74 g/4L | Jul 15, 2026 | Jul 15, 2026 |
| Affordable Pharmaceuticals, LLC | POLYETHYLENE GLYCOL 3350 236 g/4L; POTASSIUM CHLORIDE 2.97 g/4L; SODIUM BICARBONATE 6.74 g/4L; SODIUM CHLORIDE 5.86 g/4L; SODIUM SULFATE ANHYDROUS 22.74 g/4L | Jul 15, 2026 | Jul 15, 2026 |
| Azurity Pharmaceuticals, Inc. | POLYETHYLENE GLYCOL 3350 236 g/4L; POTASSIUM CHLORIDE 2.97 g/4L; SODIUM BICARBONATE 6.74 g/4L; SODIUM CHLORIDE 5.86 g/4L; SODIUM SULFATE ANHYDROUS 22.74 g/4L | Jul 15, 2026 | Jul 15, 2026 |
| Braintree Laboratories, Inc. | POLYETHYLENE GLYCOL 3350 236 g/4L; POTASSIUM CHLORIDE 2.97 g/4L; SODIUM BICARBONATE 6.74 g/4L; SODIUM CHLORIDE 5.86 g/4L; SODIUM SULFATE ANHYDROUS 22.74 g/4L | Jul 15, 2026 | Jul 15, 2026 |
| Wilshire Pharmaceuticals, Inc. | POLYETHYLENE GLYCOL 3350 236 g/4L; POTASSIUM CHLORIDE 2.97 g/4L; SODIUM BICARBONATE 6.74 g/4L; SODIUM CHLORIDE 5.86 g/4L; SODIUM SULFATE ANHYDROUS 22.74 g/4L | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "PEG 3350 and Electrolytes — NDC 50090-8020-00," retrieved September 3, 2026, https://drugdashboards.com/drug/50090802000.
Free to cite with attribution — see how the data is put together.